GMS Ventures & Investments - Director, 10%+ Owner at Outlook Therapeutics, Inc.

Issuer-level insider activity

Role
Director, 10%+ Owner
Issuer ticker
OTLK on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for GMS Ventures & Investments in Outlook Therapeutics, Inc.

Buys

Open market
Shares
+8,539,709
Avg price
$0.5855
Total value
+$5,000,000

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+8,539,709
Share %
100%
Total value
+$5,000,000

Transaction history for GMS Ventures & Investments in Outlook Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .